Table 6 ART outcome of AHD patients with TB, before and after the introduction of the WHO package of care for AHD
Characteristics | Overall (Jan2013-Sept 2018) | Jan 2013- June 2017) | July 2017-sept 2018) | P-value |
|---|---|---|---|---|
Clinical failure at 6 months | n (%) | n (%) | n (%) | |
Not failed | 81 (89.0) | 42 (89.4) | 39 (88.6) | 0.912 |
Failed | 10 (11.0) | 5 (10.6) | 5 (11.4) | |
Total | 91 | 47 | 44 | |
Immunological failure at 6 months | ||||
Not failed | 23 (92.0) | 10 (90.9) | 13 (92.9) | 1.00 a |
Failed | 2 (8.0) | 1 (9.1) | 1 (7.1) | |
Total | 25 | 11 | 14 | |
All causes mortality | ||||
Died | 5 (3.6) | 0 (0) | 5 (5.9) | 0.156 a |
Alive | 134 (96.4) | 54 (100) | 80 (94.1) | |
Total | 139 | 54 | 85 | |